Cargando…
Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector
OBJECTIVE: The transformation in cells at genetic levels stimulatesthe proliferation of cancer. The current review highlights the role of miRNA in management of cancer by altering processes of body at cellular levels. METHODS: A deep research on the literature available till date for miRNA in cancer...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437313/ https://www.ncbi.nlm.nih.gov/pubmed/32212783 http://dx.doi.org/10.31557/APJCP.2020.21.3.593 |
_version_ | 1783572611357212672 |
---|---|
author | Behl, Tapan Kumar, Chanchal Makkar, Rashita Gupta, Amit Sachdeva, Monika |
author_facet | Behl, Tapan Kumar, Chanchal Makkar, Rashita Gupta, Amit Sachdeva, Monika |
author_sort | Behl, Tapan |
collection | PubMed |
description | OBJECTIVE: The transformation in cells at genetic levels stimulatesthe proliferation of cancer. The current review highlights the role of miRNA in management of cancer by altering processes of body at cellular levels. METHODS: A deep research on the literature available till date for miRNA in cancer was conducted using various medical sites like PubMed, MEDLINE from internet and data was collected. The articles were majorly preferred in English language. RESULTS: The development of normal cells into cancerous cells is a multivalent procedure highlighting numerous responsible factors. During the progression of cancer, the role of oncogene and tumor suppressor genes outshines at different levels of tumorogenesis. Metastasis poses highest threat in cancer progression and fabricates obstacles to clinicians and researchers in preventing formation of tumor on secondary sites. The mesenchymal-epithelial transition (MET) and epithelial mesenchymal transition (EMT) induce dissemination and ultimately progression of cancer. CONCLUSION: A comprehensive knowledge of the altered genes and the mechanism by which they induce formation of tumor is essential as they contribute in proliferating cancer at various stages, aggravating clinical symptoms. Hence miRNAs can be efficiently employed as an emerging treatment therapy for cancer. |
format | Online Article Text |
id | pubmed-7437313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-74373132020-09-02 Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector Behl, Tapan Kumar, Chanchal Makkar, Rashita Gupta, Amit Sachdeva, Monika Asian Pac J Cancer Prev Review Article OBJECTIVE: The transformation in cells at genetic levels stimulatesthe proliferation of cancer. The current review highlights the role of miRNA in management of cancer by altering processes of body at cellular levels. METHODS: A deep research on the literature available till date for miRNA in cancer was conducted using various medical sites like PubMed, MEDLINE from internet and data was collected. The articles were majorly preferred in English language. RESULTS: The development of normal cells into cancerous cells is a multivalent procedure highlighting numerous responsible factors. During the progression of cancer, the role of oncogene and tumor suppressor genes outshines at different levels of tumorogenesis. Metastasis poses highest threat in cancer progression and fabricates obstacles to clinicians and researchers in preventing formation of tumor on secondary sites. The mesenchymal-epithelial transition (MET) and epithelial mesenchymal transition (EMT) induce dissemination and ultimately progression of cancer. CONCLUSION: A comprehensive knowledge of the altered genes and the mechanism by which they induce formation of tumor is essential as they contribute in proliferating cancer at various stages, aggravating clinical symptoms. Hence miRNAs can be efficiently employed as an emerging treatment therapy for cancer. West Asia Organization for Cancer Prevention 2020-03 /pmc/articles/PMC7437313/ /pubmed/32212783 http://dx.doi.org/10.31557/APJCP.2020.21.3.593 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Behl, Tapan Kumar, Chanchal Makkar, Rashita Gupta, Amit Sachdeva, Monika Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
title | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
title_full | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
title_fullStr | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
title_full_unstemmed | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
title_short | Intercalating the Role of MicroRNAs in Cancer: As Enemy or Protector |
title_sort | intercalating the role of micrornas in cancer: as enemy or protector |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437313/ https://www.ncbi.nlm.nih.gov/pubmed/32212783 http://dx.doi.org/10.31557/APJCP.2020.21.3.593 |
work_keys_str_mv | AT behltapan intercalatingtheroleofmicrornasincancerasenemyorprotector AT kumarchanchal intercalatingtheroleofmicrornasincancerasenemyorprotector AT makkarrashita intercalatingtheroleofmicrornasincancerasenemyorprotector AT guptaamit intercalatingtheroleofmicrornasincancerasenemyorprotector AT sachdevamonika intercalatingtheroleofmicrornasincancerasenemyorprotector |